These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17373321)

  • 21. [Antitubercular agents and hepatic complications].
    Ayoub A
    Tunis Med; 1984 Nov; 62(7):495-500. PubMed ID: 6531800
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinically apparent liver damage during brief tuberculosis therapy].
    Estay S; Armas Merino R; Vega C; Soto JR
    Rev Med Chil; 1981 Oct; 109(10):941-4. PubMed ID: 7344017
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H
    Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of polyunsaturated phosphatidylcholine associated with a vitamin B complex in the treatment of hepatic injuries caused by antitubercular agents].
    Lazzara A; Maucceri G; Costanzo V; Granata M
    Clin Ter; 1986 Sep; 118(6):423-6. PubMed ID: 3780172
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 27. [Classification and diagnostic strategies of drug-induced hepatic disease].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):445-6. PubMed ID: 15268822
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antimicrobial-drug induced hepatic injuries].
    Aizawa Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():601-4. PubMed ID: 17455688
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
    Can Commun Dis Rep; 2001 Jul; 27(13):114-6. PubMed ID: 11443837
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug-induced iatrogenic hepatic lesions].
    Gola A; Lukasik S; Slończewski B; Swiderska T; Teresiak T
    Pol Tyg Lek; 1972 Jan; 27(5):179-80. PubMed ID: 5010764
    [No Abstract]   [Full Text] [Related]  

  • 32. [Undesirable effects of antitubercular agents].
    Drira I; Jrad S; Ben Arif ; Souissi R; Daghfous R; Bellkahia C; Chebbi ML
    Tunis Med; 1998 Feb; 76(2):1041-6. PubMed ID: 9844539
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 34. [Danger of liver damage in modern antitubercular treatment].
    Kozma D; Lapis K; Debreczeni L
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():479-81. PubMed ID: 6647279
    [No Abstract]   [Full Text] [Related]  

  • 35. [The hepatotoxicity of antitubercular agents].
    Alegre Martín J; Fernández de Sevilla T
    An Med Interna; 1992 Nov; 9(11):523-5. PubMed ID: 1467398
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?
    Singh J; Garg PK; Thakur VS; Tandon RK
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):43-6. PubMed ID: 7705868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver and antitubercular drug therapy].
    Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA
    Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medication-induced hepatic lesions in patients with pulmonary tuberculosis].
    Gned'ko NI
    Voen Med Zh; 2002 May; 323(5):56-8. PubMed ID: 12073843
    [No Abstract]   [Full Text] [Related]  

  • 39. [Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
    Rabina EV; Semichastnova AG; Golubiatnikova GA
    Arkh Patol; 1972; 34(8):75-7. PubMed ID: 4345581
    [No Abstract]   [Full Text] [Related]  

  • 40. Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?
    Jasmer RM; Daley CL
    Am J Respir Crit Care Med; 2003 Mar; 167(6):809-10. PubMed ID: 12623855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.